ZBT-67830-87406 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-22
Registered in v-safe
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness · Chills

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Redness · Muscle or body aches

Adult check-in
2021-01-12
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Redness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-24
Survey response — 14 day, dose 2
MedDRA: Abortion spontaneous — Feeling: Fair

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Free text

Release 1

Systemic reaction (other): Ipsilateral Axillary lymphadenopathy

Systemic reaction (other): Lymphadenopathy of axilla

Release 2

Symptoms: Miscarriage

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abortion spontaneous	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release